106 related articles for article (PubMed ID: 1115798)
1. Association of the long-acting thyroid stimulator protector with the immunoglobulin G fraction of serum from patients with thyrotoxicosis.
Dirmikis SM; Justice SK; Munro DS
Biochim Biophys Acta; 1975 Jan; 379(1):239-46. PubMed ID: 1115798
[TBL] [Abstract][Full Text] [Related]
2. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
Hardisty CA; Hanford L; Humphries H; Munro DS
Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
[TBL] [Abstract][Full Text] [Related]
3. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
Adams DD; Kennedy TH; Stewart RD
Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of long-acting thyroid stimulator gamma-G binding protein.
Smith BR
Biochim Biophys Acta; 1971 Mar; 229(3):649-62. PubMed ID: 4929149
[No Abstract] [Full Text] [Related]
5. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
6. Neonatal hyperthyroidism and long-acting thyroid stimulator protector.
Nutt J; Clark F; Welch RG; Hall R
Br Med J; 1974 Dec; 4(5946):695-6. PubMed ID: 4479947
[TBL] [Abstract][Full Text] [Related]
7. Some factors affecting the detection of long-acting thyroid stimulator protector using the McKenzie bioassay.
Dirmikis S
J Endocrinol; 1974 Dec; 63(3):427-38. PubMed ID: 4217816
[No Abstract] [Full Text] [Related]
8. LATS-protector activity in thyrotoxicosis measured by thyroidal intracellular colloid droplet formation.
Shishiba Y; Miyachi Y; Takaishi M; Ozawa Y
J Clin Endocrinol Metab; 1978 May; 46(5):841-8. PubMed ID: 262769
[TBL] [Abstract][Full Text] [Related]
9. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
Amino N; Miyai K; Azukizawa M; Kumahara Y
Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
[No Abstract] [Full Text] [Related]
10. Direct evidence for human thyroidal stimulation by LATS-protector.
Shishiba Y; Shimizu T; Yoshimura S; Shizume K
J Clin Endocrinol Metab; 1973 Mar; 36(3):517-21. PubMed ID: 4739312
[No Abstract] [Full Text] [Related]
11. LATS protector, the human thyroid stimulator.
Adams DD
N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
[No Abstract] [Full Text] [Related]
12. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
Miyai K; Werner SC
J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
[No Abstract] [Full Text] [Related]
13. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
[TBL] [Abstract][Full Text] [Related]
14. Studies on the nature of plasma thyroid stimulating activity in hyperthyroidism.
Hoffman MJ; Mason EK; Good BF; Hetzel BS; Ferguson K
Australas Ann Med; 1967 May; 16(2):98-106. PubMed ID: 4167406
[No Abstract] [Full Text] [Related]
15. Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease.
Hardisty CA; Munro DS
Br Med J (Clin Res Ed); 1983 Mar; 286(6369):934-5. PubMed ID: 6403139
[TBL] [Abstract][Full Text] [Related]
16. [BASIC STUDIES ON THE LONG-ACTING THYROID STIMULATOR. 4. SEPARATION OF THE LONG-ACTING THYROID STIMULATOR AND THYROTROPIN BY DEAE-SEPHADEX A25 RECHROMATOGRAPHY].
NOGUCHI A; SATO S; KURIHARA H; OZEKI Y
Nihon Naibunpi Gakkai Zasshi; 1964 Apr; 40():5-8. PubMed ID: 14150999
[No Abstract] [Full Text] [Related]
17. Partial purification of the binding activity for the long-acting thyroid stimulator in the human thyroid.
Dirmikis S; Munro DS
J Endocrinol; 1972 Nov; 55(2):xlv-xlvi. PubMed ID: 4636369
[No Abstract] [Full Text] [Related]
18. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
Yamakido M; Yokoyama M; Noguchi S
Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
[No Abstract] [Full Text] [Related]
19. A STANDARD FOR THE LONG-ACTING THYROID STIMULATOR (LATS) IN THE SERUM OF PATIENTS WITH THYROTOXICOSIS.
DORRINGTON KJ; MUNRO DS
J Endocrinol; 1964 Nov; 31():21-8. PubMed ID: 14231127
[No Abstract] [Full Text] [Related]
20. The distribution of the long-acting thyroid stimulator among gamma G-immunoglobulins.
Smith BR; Munro DS; Dorrington KJ
Biochim Biophys Acta; 1969 Aug; 188(1):89-100. PubMed ID: 5820688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
